We further explored differences between melanoma responders and non-responders by investigating the extent of (co-) expression of 6 functional markers (CTLA-4, Ki67, IDO, PD-1, PD-L1 and HLA-DR) in the FlowSOM clusters. The gene discussed is PDCD1; the disease is melanoma.